NCT07538622 Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry
| NCT ID | NCT07538622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zenflow, Inc. |
| Condition | BPH (Benign Prostatic Hyperplasia) |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-07-29 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2026-07-29 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spring System performs during the implant procedure, and at follow-up visits at 1, 3, 6, and 12 months. We will look at how symptoms improve, how quickly patients return to normal activities, how satisfied they are with treatment, and whether there are any problems or side effects related to the device.
Eligibility Criteria
Inclusion Criteria: * Treatment with Zenflow Spring System will be conducted in accordance with the approved Instructions for Use Exclusion Criteria: * Treatment with Zenflow Spring System will be conducted in accordance with the approved Instructions for Use
Frequently Asked Questions
Who can join the NCT07538622 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying BPH (Benign Prostatic Hyperplasia). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07538622 currently recruiting?
Yes, NCT07538622 is actively recruiting participants. Visit ClinicalTrials.gov or contact Zenflow, Inc. to inquire about joining.
Where is the NCT07538622 trial being conducted?
This trial is being conducted at Phoenix, United States, La Mesa, United States, Tampa, United States, Winter Garden, United States and 4 additional locations.
Who is sponsoring the NCT07538622 clinical trial?
NCT07538622 is sponsored by Zenflow, Inc.. The trial plans to enroll 300 participants.